Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term OutcomeFederico Lussana, Alessandro Rambaldi, Claudio Romani et al.|Transplantation and Cellular Therapy|2016Cited by 88
Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AMLRenato Bassan, Alessandro Rambaldi, Tamara Intermesoli et al.|Blood Advances|2019Cited by 33
Clinical significance of chromatin-spliceosome acute myeloid leukemia: a report from the Northern Italy Leukemia Group (NILG) randomized trial 02/06Chiara Caprioli, Alessandro Rambaldi, Federico Lussana et al.|Haematologica|2020Cited by 22
High Throughput Molecular Characterization of Normal Karyotype Acute Myeloid Leukemia in the Context of the Prospective Trial 02/06 of the Northern Italy Leukemia Group (NILG)Silvia Salmoiraghi, Orietta Spinelli, Roberta Cavagna et al.|Cancers|2020Cited by 10
Outcome of Adult AML at First Relapse Following a Risk-Oriented Strategy: An Update of the Northern Italy Leukemia Group (NILG) ExperienceIrene Cavattoni, Renato Bassan, Enrico Morello et al.|Blood|2008Cited by 1